Search

Your search keyword '"Thomas, Konstantinos"' showing total 121 results

Search Constraints

Start Over You searched for: Author "Thomas, Konstantinos" Remove constraint Author: "Thomas, Konstantinos" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
121 results on '"Thomas, Konstantinos"'

Search Results

1. Structure Your Data: Towards Semantic Graph Counterfactuals

2. Choose your Data Wisely: A Framework for Semantic Counterfactuals

3. Fine-Grained ImageNet Classification in the Wild

4. Counterfactual Edits for Generative Evaluation

5. The safety and potential efficacy of exosomes overexpressing CD24 (EXO-CD24) in mild-moderate COVID-19 related ARDS

6. Urine Nephrin and Podocalyxin Reflecting Podocyte Damage and Severity of Kidney Disease in Various Glomerular Diseases—A Cross-Sectional Study

7. Cytomegalovirus-Specific Hyperimmune Immunoglobulin Administration for Secondary Prevention after First-Trimester Maternal Primary Infection: A 13-Year Single-Center Cohort Study.

8. Breakthrough COVID-19 Infections after Booster SARS-CoV-2 Vaccination in a Greek Cohort of People Living with HIV during the Delta and Omicron Waves †.

9. Progressive Multifocal Leukoencephalopathy in Systemic Lupus Erythematosus: A Consequence of Patient-Intrinsic or -Extrinsic Factors?

11. NF-kappa-B essential modulator (NEMO) gene polymorphism in an adult woman with systemic lupus erythematosus and recurrent non-tuberculous mycobacterial disseminated infections

12. Sustained cell-mediated but not humoral responses in rituximab-treated rheumatic patients after vaccination against SARS-CoV-2

13. Health-related quality of life in patients with ANCA vasculitides compared to rheumatoid arthritis: a cross-sectional comparative study

14. The genomic landscape of ANCA-associated vasculitis: Distinct transcriptional signatures, molecular endotypes and comparison with systemic lupus erythematosus

15. Patterns and factors associated with pneumococcal vaccination in a prospective cohort of 1,697 patients with rheumatoid arthritis

16. Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort study

17. Real-Life Effectiveness and Safety of Baricitinib as Adjunctive to Standard-of-Care Treatment in Hospitalized Patients With Severe Coronavirus Disease 2019

18. Μελέτη της φυσικής πορείας, εμφάνισης σοβαρών λοιμώξεων και αποτελεσματικότητας της σύγχρονης θεραπευτικής στρατηγικής σε ασθενείς με ANCA-αγγειίτιδες μέσω της δημιουργίας ηλεκτρονικού μητρώου καταγραφής (registry)

19. Myocardial work and vascular dysfunction are partially improved at 12 months after COVID ‐19 infection

20. Editorial: Infection-Related Rheumatic Diseases

21. Real-Life Effectiveness and Safety of Baricitinib as Adjunctive to Standard-of-Care Treatment in Hospitalized Patients With Severe Coronavirus Disease 2019

22. Association of COVID‐19 with impaired endothelial glycocalyx, vascular function and myocardial deformation four months after infection

24. Association of COVID‐19 with impaired endothelial glycocalyx, vascular function and myocardial deformation 4 months after infection

25. Chems4EU: chemsex use and its impacts across four European countries in HIV-positive men who have sex with men attending HIV services

27. Association of COVID-19 with impaired endothelial glycocalyx, vascular function and myocardial deformation 4 months after infection

28. COVID-19: the day after

29. Additional file 1 of Serious infections in ANCA-associated vasculitides in the biologic era: real-life data from a multicenter cohort of 162 patients

33. Incidence, risk factors and validation of the RABBIT score for serious infections in a cohort of 1557 patients with rheumatoid arthritis

34. Real-Life Effectiveness and Safety of Baricitinib as Adjunctive to Standard-of-Care Treatment in Hospitalized Patients With Severe Coronavirus Disease 2019.

35. Comparable or higher prevalence of comorbidities in antiphospholipid syndrome vs rheumatoid arthritis: a multicenter, case-control study

36. Real Life Efficacy and Safety of Secukinumab in Biologic-Experienced Patients With Psoriatic Arthritis

38. Conversion and Reversion Rates of Tuberculosis Screening Assays in Patients With Rheumatic Diseases and Negative Baseline Screening Under Long-Term Biologic Treatment

39. Interstitial Pneumonia with Autoimmune Features (IPAF): A Single-Centre, Prospective Study

41. Hypocomplementemia is associated with more severe renal disease and worse renal outcomes in patients with ANCA-associated vasculitis: a retrospective cohort study

42. Treatment patterns and achievement of the treat-to-target goals in a real-life rheumatoid arthritis patient cohort: data from 1317 patients

43. Mitophagy Balance in Various Cell Subsets in Patients with ANCA-Associated Vasculitis and Correlation with the Presence of Anti-Neutrophil Cytoplasmic Antibodies

47. Pneumocystis Jirovecii Pneumonia after Initiation of Tofacitinib Therapy in Rheumatoid Arthritis: Case-Based Review

48. INCIDENCE, RISK FACTORS AND VALIDATION OF THE RABBIT SCORE FOR SERIOUS INFECTIONS IN A REAL LIFE PROSPECTIVE STUDY OF PATIENTSWITH RHEUMATOID ARTHRITIS: DATA FROM 1.549 PATIENTS

50. Incidence, risk factors and validation of the RABBIT score for serious infections in a cohort of 1557 patients with rheumatoid arthritis.

Catalog

Books, media, physical & digital resources